---
title: AXOlabs vs Maravai LifeSciences
slug_a: axolabs
slug_b: maravai
site: cdmo
review_signal_gate: closed
canonical_path: /compare/axolabs/maravai
---

# AXOlabs vs Maravai LifeSciences

Side-by-side profile data from each company listing on this directory.

## AXOlabs

- Profile: [/companies/axolabs](/companies/axolabs)

AXOlabs — Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.

Services: 13. Modalities: 1. Indications: 0. Locations: 3. Certifications: 2. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- In Vitro Pharmacology
- In Vivo PK / PD Studies
- GLP Toxicology
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Bioinformatics & Data Science
- Oligonucleotide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Oligonucleotide

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Maravai LifeSciences

- Profile: [/companies/maravai](/companies/maravai)

Maravai LifeSciences — Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.

Services: 11. Modalities: 6. Indications: 5. Locations: 0. Certifications: 2. The strongest documented coverage currently appears in services (11).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- mRNA Manufacturing
- Oligonucleotide Manufacturing
- Vaccine Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- mRNA
- Gene Therapy
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Cell-Free